Effect of endometrial injection scratching in cycles of treatment by assisted reproductive technology methods





infertility, assisted reproductive technology methods, endometrial hypoplasia, injection endometrial scratching.


Objective: optimization of pregravid (pre-pregnancy) preparation in patients with tubal-peritoneal infertility factor and marked delay in endometrial development after unsuccessful assisted reproductive technology (ART) treatment by the use of endometrium injection scratching technology with autoplasma.

Material and methods. Study included 40 cases of unsuccessful treatment attempts for tubal-peritoneal factor infertility with severe delay of endometrial development and 10 patients with tubal-peritoneal factor infertility with normal endometrium with one or more unsuccessful ART attempts on history and the existence of cryopreserved embryos of satisfactory quality from previous cycles of assisted reproductive technology. The average age was 39.5 ± 3.1 years. Patients were divided into groups: I – 21 patients who underwent endometrial injection scratching and hormonе replacement therapy (HRT) with a standard (4/6 mg) dose of estradiol; II – 19 patients who were prescribed HRT with a standard (4/6 mg) dose of estradiol; control – 10 patients with normal endometrium who underwent cryo-ET with standard (4/6 mg) dose of estradiol.

Clinical results were evaluated and compared in terms of pregnancy rate per embryo transfer and pregnancy loss rate in the first trimester. The correspondence of the morphofunctional structure of the endometrium was evaluated by ultrasound, cytologically, Doppler measurements, histologically, immunohistochemically and via selective electron microscopy. Endometrium was 8.9 ± 1.1 mm during the period of progesterone prescription in the cryoembryo transfer cycle. All participants were transferred day 5 embryos. Results. In the cryo-ET program autoplasma injection scratching in patients with marked delay of endometrial development after the first seven days of monotherapy with a starting dose of estradiol was accompanied by a significant improvement in clinical outcomes in terms of pregnancy rate (25%) and definite decrease of early reproductive losses (25%).

Conclusions. After pre-pregnancy preparation according to our method, it is quite sufficient to perform HRT with a standard dose of estradiol (4/6 mg/day) before starting progesterone irrespective of the endometrial development degree. Meanwhile, injection scratching is advisable to be prescribed in cases of marked delay in the endometrium development and it should be combined with physiotherapy methods.

Author Biographies

L. V. Suslikova, P.L. Shupik NMAPE, Kyiv

MD, professor, director of the Ukrainian State Institute of Reproductology

V. V. Kaminskyi, P.L. Shupyk NMAPE, head of KCCRPM, Kyiv

MD, professor, corresponding member of the NAMS of Ukraine, head of the Obstetrics, Gynecology and Reproductology Department

K. V. Chayka, P.L. Shupik NMAPE, Kyiv

MD, professor of the Obstetrics, Gynecology and Reproductology Department

A. V. Kaminskyi, P.L. Shupik NMAPE, Kyiv

MD, associate professor, head of Clinic of reproductive technology,

Ukrainian State Institute of Reproductology

A. V. Serbeniuk, P.L. Shupik NMAPE, Kyiv

PhD, obstetrician-gynecologist, Clinic of reproductive technology, USIR

R. V. Zhykharskyi, KCCRPM, Kyiv

PhD, head of the Department of Endometriosis and Pelvic Surgery,

O. Y. Bondaruk, Clinics of Reproductive Technologies USIRP.L. Shupyk NMAPE, Kyiv

Graduate student, Obstetrics, Gynecology and Reproductology Department, obstetrician gynecologist


  1. Avramenko, N.V., Kabachenko, O.V., Maksimenko, V.G., Barkovskyi, D.E. “Influence of the state of expression of nuclear receptors of sex steroid hormones in the endometrium on woman reproductive function.” Zaporizhzhya Medical Journal 5 (2015): 66–8.
  2. Giulmamedova, I.D., Dotsenko, O.S., Savchenko, I.V., Giulmamedova, O.A. “Modern views on the diagnosis and correction of implant receptivity of the endometrium (literature review).” Tavricheskiy Mediko-Biologicheskiy Vestnik 16.2 Part 2.62 (2013): 169–74.
  3. Dakhno, F.V. “Use of micronized progesterone gel in IFV programs.” Female doctor 1 (2010): 16–9.
  4. Kotsabyn, N.V., Makarchuk, O.M. “The role of the morphofunctional state of the endometrium as a leading factor in the successful implantation of the fertilized egg.” Archive of clinical medicine 2.20 (2014): 8–10.
  5. Onyshchuk, O.D. “Optimizing the preparation of women for in vitro fertilization programs after unsuccessful previous attempts.” Bukovynian Medical Bulletin 3 (2011): 55–7.
  6. Giulmamedova, I.D., Ilyina O.I., Nosenko E.N. “Features of formation of endometrial pinopods with the support of the luteal phase by vaginal micronized progesterone.” Female doctor 5 (2010): 18–23.
  7. Chayka, V.K., Chayka, A.V., Nosenko, E.N. Endometrial receptivity in patients with infertility. Donetsk. Knowledge Publishing House, Donetsk Branch (2011): 243 p.
  8. Seidova, L.A., Yavorskaya, K.A. “Paracrine implantation regulators.” Problems of reproduction 3 (2010): 7–10.
  9. Sheyderman, M.G. “The problem of thin endometrium: the possibility of combined non-hormonal treatment in preparation for the procedure of in vitro fertilization.” Female doctor 6 (2016): 19–25.
  10. Shurshalina, A.V. “Pregravid preparation of an endometrium and auxiliary reproductive technologies.” Gynecology 15.2 (2013): 12–14.
  11. Shcherbina, M.O., Tkachova, O.V., Skorbach, O.I. “Preparation of the endometrium for implantation in women of reproductive age.” Neonatology, surgery and perinatal medicine 5.3 (2015): 89–93.
  12. Baum, M., Yerushalmi, G.M., Maman, E., et al. “Does local injury to the endometrium before IVF cycle really affect treatment outcome? Results of a randomized placebo controlled trial.” Gynecol Endocrinol 28 (2012): 933–6.
  13. Ferraretti, A.P., Goossens, V., Kupka, M., et al. “Assisted reproductive technology in Europe, 2009: Results generated from European registers by ESHRE.” Hum Reprod 28 (2013): 2318–31.
  14. Bettocchi, S., Achilarre, M.T., Ceci, O., et al. “Fertility-enhancing hysteroscopic surgery.” Seminars in Reproductive Medicine 29 (2011): 75–82.
  15. Garcia Velasco, J. Auto-immunity and/or thrombophilia as causes for recurrent implantation failure: myth or reality? Instituto Valenciano de Infertilidad, Reproductive Endocrinology and Infertility. Madrid (2012).
  16. Granot, I., Gnainsky, Y., Dekel, N. “Endometrial inflammation and effect on implantation improvement and pregnancy outcome.” Reproduction 44 (2012): 61.
  17. Guven, S., Kart, C., Unsal, M.A., et al. “Endometrial injury may increase the clinical pregnancy rate in normoresponders undergoing long agonist protocol ICSI cycles with single embryo transfer.” Eur J Obstet Gynecol Reprod Biol 173 (2014): 58–62.
  18. Lensen, S., Sadler, L., Farquhar, C. “Endometrial scratching for subfertility: Everyone’s doing it.” Hum Reprod 31 (2016): 1241–4.
  19. Li, T.C. Evidence based management of the couple with recurrent implantation failure. ESHRE (2012): O¬088.
  20. Macklon, N. “Laboratory: The embryo¬endometrial interface – role in implantation/developmental success.” The contribution of the endometrium University of Southampton, Academic Unit of Human Health and Development Mailpoint. ESHRE: 29th Annual Meeting. Paramedical invited session. – London, UK, 7–10 July 2013.
  21. Nastri, C.O., Ferriani, R.A., Raine-Fenning, N., et al. “Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial.” Ultrasound Obstet Gynecol 42 (2013): 375–82.
  22. Nastri, C.O., Lensen, S.F., Gibreel, A., et al. “Endometrial injury in women undergoing assisted reproductive techniques.” Cochrane Database Syst Rev 3 (2015): CD009517.
  23. Panagiotopoulou, N., Karavolos, S., Choudhary, M. “Endometrial injury prior to assisted reproductive techniques for recurrent implantation failure: a systematic literature review.” Eur J Obstet Gynecol Reprod Biol 193 (2015): 27–33.
  24. Singh, N., Toshyan, V., Kumar, S., et al. “Does endometrial injury enhances implantation in recurrent in-vitro fertilization failures? A prospective randomized control study from tertiary care center.” J Hum Reprod Sci 8.4 (2015): 218–23.
  25. Bosteels, J., Kasius, J., Weyers, S., et al. “Treating suspected uterine cavity abnormalities by hysteroscopy to improve reproductive outcome in women with unexplained infertility or prior to IUI, IVF, or ICSI.” Gynecological Surgery 10 (2013): 165–7.
  26. Vélez, M.P., Connolly, M.P., Kadoch, I., et al. “Universal coverage of IVF pays off.” Hum Reprod 29 (2014): 1313–9.




How to Cite

Suslikova, L. V., Kaminskyi, V. V., Chayka, K. V., Kaminskyi, A. V., Serbeniuk, A. V., Zhykharskyi, R. V., & Bondaruk, O. Y. (2020). Effect of endometrial injection scratching in cycles of treatment by assisted reproductive technology methods. REPRODUCTIVE ENDOCRINOLOGY, (53), 49–54. https://doi.org/10.18370/2309-4117.2020.53.49-54